These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15792566)

  • 21. Prevention of central venous catheter-related infections: what works other than impregnated or coated catheters?
    Mermel LA
    J Hosp Infect; 2007 Jun; 65 Suppl 2():30-3. PubMed ID: 17540238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on antimicrobial central venous catheters.
    Elliott TS
    J Hosp Infect; 2007 Jun; 65 Suppl 2():34-8. PubMed ID: 17540239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study.
    Secer HI; Kural C; Kaplan M; Kilic A; Duz B; Gonul E; Izci Y
    Pediatr Neurosurg; 2008; 44(6):444-7. PubMed ID: 19018152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorhexidine: expanding the armamentarium for infection control and prevention.
    Milstone AM; Passaretti CL; Perl TM
    Clin Infect Dis; 2008 Jan; 46(2):274-81. PubMed ID: 18171263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of catheter-related infection.
    Pagani JL; Eggimann P
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):31-7. PubMed ID: 18251662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
    Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for preventing catheter-related bloodstream infections: the role of new technologies.
    Lubelchek RJ; Weinstein RA
    Crit Care Med; 2006 Mar; 34(3):905-7. PubMed ID: 16505678
    [No Abstract]   [Full Text] [Related]  

  • 28. Inconsistencies in a study of rifampicin-miconazole-impregnated catheters versus standard catheters.
    Trikalinos NA; Trikalinos TA
    Clin Infect Dis; 2009 Mar; 48(6):841-2; author reply 842. PubMed ID: 19220154
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU.
    Frank U; Chojnacki T; Dettenkofer M; Daschner FD
    Intensive Care Med; 2003 Jan; 29(1):139. PubMed ID: 12528036
    [No Abstract]   [Full Text] [Related]  

  • 30. Increase in catheter insertion-site infections associated to the introduction of a substandard competitive antiseptic.
    Volkow P; Sandoval S; Campos AM; Gutiérrez M; de Romero C; Viana Aguiluz JJ; Perez Padilla JR
    Am J Infect Control; 2006 Aug; 34(6):335-7. PubMed ID: 16877099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations and reports about central venous catheter-related infection.
    Bacuzzi A; Cecchin A; Del Bosco A; Cantone G; Cuffari S
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S65-7. PubMed ID: 16895510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and prevention of catheter-related infections.
    Timsit JF
    Curr Opin Crit Care; 2007 Oct; 13(5):563-71. PubMed ID: 17762237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of catheter-related blood stream infection.
    Byrnes MC; Coopersmith CM
    Curr Opin Crit Care; 2007 Aug; 13(4):411-5. PubMed ID: 17599011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of corporate Six Sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU.
    Frankel HL; Crede WB; Topal JE; Roumanis SA; Devlin MW; Foley AB
    J Am Coll Surg; 2005 Sep; 201(3):349-58. PubMed ID: 16125067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Silver coated urinary catheters. Clinical effectiveness and cost-benefit analysis].
    Panknin HT
    Med Monatsschr Pharm; 2005 Oct; 28(10):368-70. PubMed ID: 16245460
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I; Reitzel R; Jiang Y; Chemaly RF; Dvorak T; Hachem R
    J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four country healthcare associated infection prevalence survey 2006: risk factor analysis.
    Humphreys H; Newcombe RG; Enstone J; Smyth ET; McIlvenny G; Fitzpatrick F; Fry C; Spencer RC;
    J Hosp Infect; 2008 Jul; 69(3):249-57. PubMed ID: 18550214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic-impregnated catheters for prevention of bloodstream infection.
    George J
    Lancet; 2016 Nov; 388(10057):2235. PubMed ID: 27825502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.